by Jordana Choucair | Oct 28, 2022 | Opioid/Substance Use Disorders
McKinsey & Co agreed to settle claims by hundreds of U.S. local governments and school districts over its role advising opioid manufacturers in their sales of the painkillers which helped fuel the opioid epidemic. The terms of the deal not made public. McKinsey...
by Jordana Choucair | Oct 26, 2022 | Opioid/Substance Use Disorders
An article in Stat explores how terminology used in the field of addiction medicine is out of sync with that of other specialties and impacts the way health professionals view their patients and provide care. Experts point out that using terms such as “alcoholic” or...
by Jordana Choucair | Oct 24, 2022 | Opioid/Substance Use Disorders
Senator Dick Durbin and Representative Lauren Underwood wrote a letter urging the Centers for Medicare & Medicaid Services (CMS) to expand Medicare’s coverage of substance use disorder (SUD) to address key gaps exacerbating the addiction crisis. The lawmakers...
by Jordana Choucair | Oct 21, 2022 | Opioid/Substance Use Disorders
The White House will release a plan today calling on the DOJ, the Department of Veterans Affairs, and the Indian Health Service to expand the use of medicines such as buprenorphine and methadone in pregnant women. Under the blueprint, Substance Abuse and Mental Health...
by Jordana Choucair | Oct 17, 2022 | Opioid/Substance Use Disorders
Senior Director Tym Rourke was interviewed for a HuffPost article about the availability and use of Narcan in New Hampshire. The article was written in response to a political candidate’s comments that that the treatment, which is used to stop the symptoms of an...
by Jordana Choucair | Oct 11, 2022 | Opioid/Substance Use Disorders
A Kaiser Health News investigation found that many hospitals don’t have specialists who know how to treat addiction. While hospitals employ numerous clinicians – physicians, nurses, therapists, or social workers – who can support patients with heart, lung, or kidney...
Recent Comments